Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine.

Bracha S, McNamara M, Hilgart I, Milovancev M, Medlock J, Goodall C, Wickramasekara S, Maier CS.

Anal Biochem. 2014 Jun 15;455:41-7. doi: 10.1016/j.ab.2014.03.017.

2.

Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs.

Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R, Garrett LD, McCaw DL, Higginbotham ML, Flessland KA, Stokes PK.

Am J Vet Res. 2003 Aug;64(8):1017-20.

PMID:
12926595
3.

High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.

Allen DK, Waters DJ, Knapp DW, Kuczek T.

J Vet Intern Med. 1996 Jul-Aug;10(4):231-4.

4.

Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.

Sotirakopoulos AJ, Armstrong PJ, Heath L, Madrill NJ, McNiel EA.

J Vet Intern Med. 2010 Nov-Dec;24(6):1445-51. doi: 10.1111/j.1939-1676.2010.0617.x.

5.

Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.

Tyan YC, Yang MH, Chen SC, Jong SB, Chen WC, Yang YH, Chung TW, Liao PC.

Rapid Commun Mass Spectrom. 2011 Oct 15;25(19):2851-62. doi: 10.1002/rcm.5169.

PMID:
21913264
6.

NMR-based metabolomics study of canine bladder cancer.

Zhang J, Wei S, Liu L, Nagana Gowda GA, Bonney P, Stewart J, Knapp DW, Raftery D.

Biochim Biophys Acta. 2012 Nov;1822(11):1807-14. doi: 10.1016/j.bbadis.2012.08.001.

7.

Measurement of urinary canine S100A8/A9 and S100A12 concentrations as candidate biomarkers of lower urinary tract neoplasia in dogs.

Heilmann RM, Wright ZM, Lanerie DJ, Suchodolski JS, Steiner JM.

J Vet Diagn Invest. 2014 Jan;26(1):104-12. doi: 10.1177/1040638713516625.

PMID:
24398905
8.

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.

Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright Jr GL Jr.

Am J Pathol. 2001 Apr;158(4):1491-502.

9.

Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine.

McCleary-Wheeler AL, Williams LE, Hess PR, Suter SE.

Am J Vet Res. 2010 Dec;71(12):1468-74. doi: 10.2460/ajvr.71.12.1468.

PMID:
21117999
10.

Epidermal growth factor receptor expression in canine transitional cell carcinoma.

Hanazono K, Fukumoto S, Kawamura Y, Endo Y, Kadosawa T, Iwano H, Uchide T.

J Vet Med Sci. 2015 Jan;77(1):1-6. doi: 10.1292/jvms.14-0032.

11.

Urinary biomarker profiling in transitional cell carcinoma.

Munro NP, Cairns DA, Clarke P, Rogers M, Stanley AJ, Barrett JH, Harnden P, Thompson D, Eardley I, Banks RE, Knowles MA.

Int J Cancer. 2006 Dec 1;119(11):2642-50.

12.

Management of transitional cell carcinoma of the urinary bladder in dogs: a review.

Fulkerson CM, Knapp DW.

Vet J. 2015 Aug;205(2):217-25. doi: 10.1016/j.tvjl.2015.01.017. Review.

PMID:
25747698
13.

Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.

Rankin WV, Henry CJ, Turnquist SE, Turk JR, Beissenherz ME, Tyler JW, Rucker EB, Knapp DW, Rodriguez CO, Green JA.

Vet Comp Oncol. 2008 Sep;6(3):141-50. doi: 10.1111/j.1476-5829.2007.00150.x.

PMID:
19178674
15.

Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.

Knapp DW, Ramos-Vara JA, Moore GE, Dhawan D, Bonney PL, Young KE.

ILAR J. 2014;55(1):100-18. doi: 10.1093/ilar/ilu018. Review.

PMID:
24936033
16.

Canine transitional cell carcinoma.

Mutsaers AJ, Widmer WR, Knapp DW.

J Vet Intern Med. 2003 Mar-Apr;17(2):136-44. Review.

17.

Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.

Kumar P, Nandi S, Tan TZ, Ler SG, Chia KS, Lim WY, B├╝tow Z, Vordos D, De la Taille A, Al-Haddawi M, Raida M, Beyer B, Ricci E, Colombel M, Chong TW, Chiong E, Soo R, Park MK, Ha HK, Gunaratne J, Thiery JP.

Oncotarget. 2015 May 30;6(15):13539-49.

18.

Cutaneous metastasis of transitional cell carcinoma in 12 dogs.

Reed LT, Knapp DW, Miller MA.

Vet Pathol. 2013 Jul;50(4):676-81. doi: 10.1177/0300985812465326.

PMID:
23136183
19.

Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

Arnold EJ, Childress MO, Fourez LM, Tan KM, Stewart JC, Bonney PL, Knapp DW.

J Vet Intern Med. 2011 Nov-Dec;25(6):1385-90. doi: 10.1111/j.1939-1676.2011.00796.x.

20.

Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.

Rankin WV, Henry CJ, Turnquist SE, Turk JR, Beissenherz ME, Tyler JW, Green JA.

Am J Vet Res. 2008 Aug;69(8):1073-8. doi: 10.2460/ajvr.69.8.1073.

PMID:
18672973
Items per page

Supplemental Content

Support Center